Navigation Links
MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations

320, Poster Board #303, presented in a poster session titled, "Innate and Immune Mechanisms of Inflammation in Microbial Pathogenesis" on Monday, May 21 at 8:15 a.m.) -- "Occurrence of Mast Cells and Basophils in Central and Peripheral Airways of Patients with Mild Asthma" (Publication Page A455, Poster Board #D18, presented in a poster session titled, "Mast Cells," on Monday, May 21 at 8:15 a.m.) -- "Enzymatically Inactive Chitinase-Like Protein YKL-40 Promotes Macrophage Activation and Lung Inflammation" (Publication Page A471, Poster Board #D63, presented in a poster session titled, "Macrophages and Lymphocytes," on Monday, May 21 at 8:15 a.m.) -- "IL-33 Is a Potent Activator of Mast Cells" (Publication Page A456, Poster Board #D19, presented in a poster session titled, "Mast Cells," on Monday, May 21 at 8:15 a.m.) -- "A Central Role for IL-9 in Regulating Mast Cell Progenitor Trafficking and Lung Inflammation After Allergen Challenge" (Publication Page A798, Poster Board #910, presented in a poster session titled, "Cytokine and Chemokine Regulation of Lung Inflammation," on Tuesday, May 22 at 1:30 p.m.) -- "Central Role of IL-9 in Allergen-Induced Airway Remodeling" (Publication Page A798, Poster Board #913, presented in a poster session titled, "Cytokine and Chemokine Regulation of Lung Inflammation" on Tuesday, May 22 at 1:30 p.m.) -- "Antibody Responses in Primary RSV Bronchiolitis Are T-Lymphocyte Independent" (Publication Page A761, presented in a poster session titled, "Modeling RSV Infection and Host Response," on Tuesday, May 22 at 3 p.m.) -- "Modeling the Interaction Between Aeroallergens and the Immune System In Vivo" (Publication Page A929, Poster Board #G92, presented in a poster session titled, "Modulation of Immunologic Inflammation in
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
2. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
3. MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
4. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
5. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
6. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
7. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
8. Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
9. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
10. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
11. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
Post Your Comments:
(Date:7/6/2015)... 2015 Akcea Therapeutics, a wholly-owned subsidiary ... announced today that the U.S. Food and Drug ... (ISIS-APOCIII Rx ) for the treatment of patients ... rare genetic disease characterized by extremely high triglyceride ... 2 study published in the NEJM in December ...
(Date:7/6/2015)... 6, 2015 /PRNewswire/ -- China Nepstar Chain Drugstore Ltd. (NYSE: ... retail drugstore chain in China ... announced that its board of directors has received a ... Simin Zhang , chairman of the board of ... Ltd., an investment vehicle wholly owned by Mr. Zhang(" ...
(Date:7/4/2015)... Spanje, July 4, 2015 ... aan eerstelijns chemotherapie voor patiënten met niet-resectabele ... verlengt de progressievrije overleving in dat orgaan. ... colorectale kanker (mCRC) die alleen binnen de ... in progressievrije overleving (PFS) in de lever ...
Breaking Medicine Technology:Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 2China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 3China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 4China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 5China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 6Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5
... Correlated With Clinical Response, CHICAGO, May ... today highlighted the potential of its,investigational MAGE-A3 ... studies evaluating highly targeted immunotherapy,as a treatment ... cancer,(NSCLC). These data were presented at the ...
... in preventing ... Contrast-Induced Nephropathy, FRANKLIN, Mass., May 30 ... on innovative cardiac and vascular medical,device-based technologies, announced today that ... Milan, Italy has,approved the planned randomized clinical trial to evaluate ...
Cached Medicine Technology:New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 2New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 3New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 4New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 5New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 6New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 7PLC Systems Announces Approval of First European Study to Evaluate RenalGuard(TM) 2PLC Systems Announces Approval of First European Study to Evaluate RenalGuard(TM) 3PLC Systems Announces Approval of First European Study to Evaluate RenalGuard(TM) 4PLC Systems Announces Approval of First European Study to Evaluate RenalGuard(TM) 5
(Date:7/5/2015)... ... ... Women’s Excellence in Wellness, powered by Movestrong is offering a student special ... months of unlimited classes for just $65. Student ID is needed at registration. , ... in Lake Orion. , Women’s Excellence is the most comprehensive obstetric ...
(Date:7/4/2015)... ... July 04, 2015 , ... When a hacker gains access to someone’s email account, ... the office. On Wednesday, July 1st, the FTC issued a scam alert about a ... a verification process for a password reset instigated by the hacker. All they have ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... its 2015 Annual Conference , the premiere continuing education and networking ... Orlando at SeaWorld in Orlando, Florida. Speakers include the leading rheumatology experts ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Erie ... 25, 2015 at 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy Esq. of ... and practical points of investigating these types of cases. , Each year, New ...
(Date:7/3/2015)... , ... July 03, 2015 , ... " Selfie on ... which features the latest and coolest technology products available to consumers. Amanda Forstrom, a ... how these selfie sticks are great for documenting memories. , Almost every smartphone has ...
Breaking Medicine News(10 mins):Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 4Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Learn How to Take Selfies like Kendall Jenner 2
... molecule sops up bad lipoproteins, researchers say , , ... high-density lipoprotein (HDL) -- the "good" cholesterol -- ... levels and the deadly cardiovascular disease it can ... University researchers, is close in size to natural ...
... PARK, N.J., Jan. 30 Americans resolving to eat ... ahead are also likely to look for ways to ... costs while increasing nutritional intake? Dr. Praeger,s Sensible Foods, ... simple solutions to encourage Americans to get on the ...
... Traumatic brain injury (TBI) has been identified as ... Afghanistan. , TBI is known to cause ... in conjunction with post-traumatic stress disorder (PTSD), depression, anxiety ... veterans have been diagnosed with TBI, based on statistics ...
... Jan. 30 Stryker Corporation (NYSE: SYK ... Meeting on Wednesday, May 20, 2009, at 8:00 a.m. ... President and Chief Executive Officer, will host the meeting ... units.A simultaneous webcast of the meeting will be available ...
... Tenn., Jan. 30 Smith & Nephew, Inc.,(NYSE: ... that its Orthopaedics Reconstruction,Division has entered into a ... Foundation (OREF). , Under ... third-party,administrator of grants, OREF will assist Smith & ...
... Fla., Jan. 30 LifeSync Corporation, a wireless ECG ... for the sale of the LifeSync(R) Wireless ECG System ... Chain Systems effective February 1, 2009. MedAssets Supply Chain ... supply chain services in U.S., serving more than 125 ...
Cached Medicine News:Health News:Synthetic HDL Could Fight Heart Disease 2Health News:Lower Your Grocery Bill, Improve Health In 2009: Top Tips From Dr. Praeger's Sensible Foods 2Health News:Lower Your Grocery Bill, Improve Health In 2009: Top Tips From Dr. Praeger's Sensible Foods 3Health News:Study of Iraq veterans' traumatic brain injuries to be conducted by UB researchers 2Health News:Stryker to Host Analyst Meeting 2Health News:Smith & Nephew Announces Agreement with the OREF Regarding Grants to Support Research and Education in Orthopaedics 2Health News:Smith & Nephew Announces Agreement with the OREF Regarding Grants to Support Research and Education in Orthopaedics 3Health News:Smith & Nephew Announces Agreement with the OREF Regarding Grants to Support Research and Education in Orthopaedics 4Health News:LifeSync Corporation Awarded Multiyear Agreement with MedAssets Supply Chain Systems for the LifeSync(R) Wireless ECG System 2
... CT MIYABI system is a ... CT scanner on rails (Sliding ... angiography unit. Both systems use ... which can be switched between ...
Spring Type with lock. Titanium....
... ease of the World's First Hand-Held Autorefractor/Keratometer. ... accuracy, reliability and performance Share the Retinomax ... no wires to limit, you can use ... range and advanced measurement modes. Readings ...
Introducing the Guidant HEARTSTRING Proximal Seal System. A surgically intuitive system that meets the challenge of clampless hemostasis with a design that is elegant in its simplicity and profound i...
Medicine Products: